ENAFF yields 116.96% · MRK yields 2.76%● Live data
📍 ENAFF pulled ahead of the other in Year 1
Combined, ENAFF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ENAFF + MRK for your $10,000?
Enablence Technologies Inc., together with its subsidiaries, designs, manufactures, and sells optical components and subsystems for local access topologies, metro, and long-haul markets in Canada and the United States. The company provides silica-based PLC optical chips used in both multiplexer and demultiplexer assembly applications and can support 400G and higher bandwidth speeds; and optical chips to serve CWDM-NRZ and FR4-PAM4 applications. It also offers coarse wavelength division multiplexing, a preferred protocol for datacenter networks; LAN-wavelength division multiplexing for 5G networks and datacenters; and dense wavelength division multiplexing, an original driver of optical telecommunications. The company serves telecommunications, cloud data centers, sensor systems, and aerospace and research applications. Enablence Technologies Inc. was incorporated in 2006 and is headquartered in Ottawa, Canada.
Full ENAFF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.